Pacific Edge - 4Q24 — Battening Down the Hatches
Pacific Edge's (PEB) 4Q24 update all but confirmed the halt in momentum, with lab throughput down -19% versus 4Q23 and broadly flat versus 3Q24
254 Views
Pacific Edge - 3Q24 — Cost and Revenue Decline
Pacific Edge's (PEB) 3Q24 update highlights ongoing softness in lab throughput with -8% year on year and -16% sequential declines as it reduces its...
217 Views
Pacific Edge - Rubber Approaching the Road
Pacific Edge’s (PEB) 2Q24 test volumes highlighted slowing momentum with +8% year on year growth and a -12% sequential decline.
479 Views
Pacific Edge - 1H24 Result — Kaiser Time
While it has undertaken significant cost reductions to right size the business and manage cash flow this was not seen in its 1H24 result, with most...
404 Views
Pacific Edge (PEB): LCD Update – Signs of Life
The implementation of LCD, L35396 “Genetic Testing for Oncology” that would have resulted in Pacific Edge’s (PEB) CMS reimbursement ceasing on 17...
339 Views